NDM-1 Treatment

Recent Posts

• NDM-1 Resistant to Colistin in a French Community Patient without History of Foreign Travel
• Tigecycline and Colistin against NDM-1 – Not a winning combo?
• Cephalosporin-resistant Shigella flexneri over 9 years (2001–09) in India
• E. coli resistance to ciprofloxacin increased for UTIs five fold in decade
• We’re Using More of the Few Antibiotics Left
• Indias Role In Incubating Drug-Resistant Bacteria
• Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
• Acinetobacter baumannii strain carrying the blaNDM-1 genes from the Czech Republic
• Transmission of carbapenem-resistant pathogens in New York City
• Emergence of NDM-1-producing Acinetobacter baumannii in Belgium
• Emergence of NDM-1-producing Enterobacteriaceae in China
• Targeting Pan-Resistant Bacteria With Antibodies to a Surface Polysaccharide
• PhoP-PhoQ and PmrA-PmrB and colistin against Pseudomonas aeruginosa
• HK detects new case of antibiotic resistant bacteria
• Antibiotic Resistance Spreads Through Environment, Threatens Modern Medicine
• Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections
• In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
• Pakistan: Health care-associated infections major issue
• Impact of cefepime therapy on ESBL infections
• Concerns over Drug Resistance in Gram-Negative Infections
• Relentless increase of resistance to fluoroquinolones & ESBL cephalosporins in E coli: 20 years – Latin America
• Emergence of ESBL E coli and Klebsiella pneumoniae isolates in Helsinki, Finland
• ESBL and AmpC from livestock and companion animals, and their putative impact on public health
• ESBLs in Tamil Nadu
• 3% patients’ bacteria samples show total resistance – Indian Express